BioSpace News Archive

Full year 2019 GOCOVRI® product sales of $54.6 million, a 60% increase over 2018; total paid prescriptions grew approximately 66% to 25,780

Vanda Pharmaceuticals Inc. announced financial and operational results for the fourth quarter and full year ended December 31, 2019.

Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the fourth quarter and full year ended December 31, 2019.

Ironwood Pharmaceuticals, Inc. will present corporate updates at two upcoming investor conferences in March

Veracyte, Inc., announced financial results and business progress for the quarter and full year ended December 31, 2019, and provided financial guidance for 2020.

Vertex Pharmaceuticals Incorporated announced that management will present at the Cowen Health Care Conference on Tuesday, March 3, 2020 at 10:00 a.m. ET..

Tradipitant antipruritic effects not seen in moderate or severe Atopic Dermatitis and the study did not meet its primary endpoint

Analysis for the co-primary endpoint of objective response rate and an interim analysis of progression-free survival expected in the second half of 2020

Castlight Health, Inc., a leading health benefits platform provider, announced results for its fourth quarter and full year ended December 31, 2019.

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, announced that Helen Collins, M.D., Executive Vice President and Chief Medical Officer, is scheduled to present at the following investor conference